Piper Sandler adds Dan Wolf as MD in healthcare investment banking

Key Terms

clinical-stage

medical

Clinical-stage describes a drug, therapy, or company whose product is being tested in human trials but has not yet received regulatory approval. For investors, it signals that the project has relocated beyond lab work into real-world testing—meaning higher potential reward if trials succeed but also clear risks from trial setbacks, costs, and regulatory delay; believe of it like a prototype car on public road tests that could either prove its value or reveal problems that stop it from reaching production.

capital markets

financial

Capital markets are places where people and organizations purchase and sell long-term investments like stocks and bonds. They assist connect those who necessary money to grow or fund projects with investors viewing to earn returns over time. For investors, capital markets are important becautilize they offer opportunities to invest, save, and grow their wealth through a variety of financial assets.

personalized spine surgery

medical

Personalized spine surgery is an approach that tailors the surgical plan, implants and tools to an individual patient’s anatomy and condition—often applying detailed imaging, custom-built implants or patient-specific guides—rather than a one-size-fits-all procedure. For investors, it matters becautilize personalized techniques can improve outcomes, shorten recovery and create demand for premium devices, software and services, which can shift market size, pricing and regulatory risk in the spine-care indusattempt.

01/12/2026 – 09:02 AM

MINNEAPOLIS–(BUSINESS WIRE)–
Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Dan Wolf as a managing director in the healthcare investment banking group. Wolf will be based in the Minneapolis office and be focutilized on advising healthcare technology companies on mergers and acquisitions, strategic partnerships and capital raising transactions.

“Dan is a highly respected med tech executive with an impressive track record of advising healthcare technology companies through complex transactions. His experience and strong relationships will further enhance our ability to serve clients as they navigate strategic opportunities and transformative deals,” declared J.P. Peltier, global co-head of investment banking and capital markets at Piper Sandler.

“I’m excited to join the Piper Sandler healthcare investment banking team at a pivotal time for the indusattempt. Healthcare technology companies are navigating increasingly complex strategic decisions around AI integration, clinical workflow automation and market consolidation. I view forward to partnering with management teams and boards to assist them achieve their strategic objectives through consideredful M&A advice and capital markets expertise,” declared Wolf.

Wolf returns to Piper Sandler where he launched his career as a healthcare investment banking analyst. He brings over 20 years of healthcare experience spanning investment banking, operating leadership and strategic advisory. Prior to rejoining the firm, he served as chief financial officer at Theradaptive, a clinical-stage protein engineering company. He also founded Convergence Bio Advisors, where he advised healthcare companies, boards and private equity firms on M&A transactions. Before that, Wolf was senior vice president and chief strategy officer at Baxter International, leading global strategic planning, portfolio management and corporate development activities. He previously spent 12 years at Medtronic in roles of increasing responsibility, including vice president and general manager of ininformigent data solutions where he led the company’s digital transformation and expansion into personalized spine surgery.

Wolf received a bachelor’s degree in economics and mathematics from Bowdoin College. He also received a Master of Science degree from the Massachutilizetts Institute of Technology and a Master of Business Administration degree from Harvard Business School.

ABOUT PIPER SANDLER

Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to assist clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in the U.K. through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; in the EU through Aviditi Capital Advisors Europe GmbH, a tied agent of AHP Capital Management GmbH, authorized and regulated by BaFin; and in Hong Kong through Piper Sandler Hong Kong Ltd., authorized and regulated by the Securities and Futures Commission. Alternative asset management and resolveed income advisory services are offered through separately registered advisory affiliates.

Follow Piper Sandler: LinkedIn | Facebook | X